Loading...
News & Media2020-11-24T19:40:26-05:00

Bridge Medicines Enters Agreement with Memorial Sloan Kettering to Develop Kidney‐Specific Delivery Platform for the Treatment of Acute Kidney Injury

July 23, 2018|
Go to Top